Blog
Gaize, Inc. closes $1.2 million USD seed financing for their non-invasive cannabis impairment detection device
Gaize, Inc. has announced receipt of $1.2 million in seed capital for their non-invasive, real-time cannabis impairment detection device. The product will be sold to law enforcement agencies, and businesses with safety-critical employees.
Why aren’t cannabis breathalyzers the right solution?
Several cannabis breathalyzers are entering the market. Unfortunately, given the way THC works in the body, none of these can measure active cannabis impairment. Here’s why.
Why are we building Gaize?
We often get the question of why we’re building Gaize. The lack of a real-time cannabis impairment testing device is one of the most pressing technology gaps in our society today. Learn all about our motivations; click here.
